Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Safety, Efficacy and Pharmacokinetic Study of PRLX 93936 in Patients With Multiple Myeloma

This study is currently recruiting participants. (see Contacts and Locations)
Verified May 2013 by Prolexys Pharmaceuticals
Sponsor:
Information provided by (Responsible Party):
Prolexys Pharmaceuticals
ClinicalTrials.gov Identifier:
NCT01695590
First received: September 18, 2012
Last updated: May 31, 2013
Last verified: May 2013
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: September 2014
  Estimated Primary Completion Date: March 2014 (Final data collection date for primary outcome measure)